6-Fluoro-3-(1-((1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-yl)methyl)piperidin-4-yl)benzo[d]isoxazole

ID: ALA3740256

Chembl Id: CHEMBL3740256

PubChem CID: 127041705

Max Phase: Preclinical

Molecular Formula: C25H27F4N3O3S

Molecular Weight: 525.57

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=S(=O)(c1ccc(C(F)(F)F)cc1)N1CCC(CN2CCC(c3noc4cc(F)ccc34)CC2)CC1

Standard InChI:  InChI=1S/C25H27F4N3O3S/c26-20-3-6-22-23(15-20)35-30-24(22)18-9-11-31(12-10-18)16-17-7-13-32(14-8-17)36(33,34)21-4-1-19(2-5-21)25(27,28)29/h1-6,15,17-18H,7-14,16H2

Standard InChI Key:  LIHYUCWMNKTEOX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3740256

    ---

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd3 Dopamine D3 receptor (1050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2a Serotonin 2a (5-HT2a) receptor (3540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1a Serotonin 1a (5-HT1a) receptor (8655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Histamine H1 receptor (2054 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2c Serotonin 2c (5-HT2c) receptor (1134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra2c Adrenergic receptor alpha-2 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 525.57Molecular Weight (Monoisotopic): 525.1709AlogP: 5.27#Rotatable Bonds: 5
Polar Surface Area: 66.65Molecular Species: BASEHBA: 5HBD: 0
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.01CX LogP: 4.32CX LogD: 2.71
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: -1.82

References

1. Chen Y, Lan Y, Cao X, Xu X, Zhang J, Yu M, Liu X, Liu B, Zhang G.  (2015)  Synthesis and evaluation of amide, sulfonamide and urea benzisoxazole derivatives as potential atypical antipsychotics,  (5): [10.1039/C4MD00578C]

Source